# Weekly Online CT or MR Adaptive Definitive SBRT for Very High Risk Localized or Regionally Metastatic Prostate Cancer

> **NCT07591051** · NA · NOT_YET_RECRUITING · sponsor: **University of Zurich** · enrollment: 54 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **DEVICE:** weekly CT or MR online adaptive definitive SBRT

## Key facts

- **NCT ID:** NCT07591051
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05
- **Primary completion:** 2028-07
- **Final completion:** 2033-07
- **Target enrollment:** 54 (ESTIMATED)
- **Last updated:** 2026-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07591051

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07591051, "Weekly Online CT or MR Adaptive Definitive SBRT for Very High Risk Localized or Regionally Metastatic Prostate Cancer". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT07591051. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*